Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Results symbols : PLRX save search
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Results
Published: 2024-02-27 (Crawled : 21:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: 4.59%
H: 0.0%
C: -7.67%
update therapeutics financial results
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: 10.0%
H: 2.94%
C: -11.46%
update therapeutics financial results
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Published: 2023-08-09 (Crawled : 20:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: 1.21%
H: 8.04%
C: 2.07%
update therapeutics financial results
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
Published: 2023-05-09 (Crawled : 20:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: 1.55%
H: 3.59%
C: 0.74%
update therapeutics financial results
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2022 Financial Results
Published: 2023-03-09 (Crawled : 00:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: 3.43%
H: 0.0%
C: -5.31%
therapeutics financial update results
CORRECTION - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 01:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: -3.85%
H: 11.9%
C: 8.33%
financial results therapeutics report results
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
Published: 2021-11-09 (Crawled : 22:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: -0.97%
H: 4.82%
C: 1.53%
financial results results
Pliant Therapeutics Reports Positive Interim Results from Phase 2a PET Imaging Clinical Trial in Patients with Idiopathic Pulmonary Fibrosis
Published: 2021-09-07 (Crawled : 12:00) - biospace.com/
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: 15.61%
H: 9.86%
C: -12.91%
phase 2 fibrosis positive results trial imaging phase 2b
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
Published: 2021-05-10 (Crawled : 21:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: -2.43%
H: 12.57%
C: 10.49%
financial results results
Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Published: 2021-03-16 (Crawled : 21:00) - globenewswire.com
PLRX | $12.51 2.63% 2.56% 310K
|
Health Technology
|
| O: -0.39%
H: 4.3%
C: 4.3%
financial results results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.